CTRI/2020/04/024655 [Registered on: 15/04/2020] Trial Registered Prospectively
Last Modified On:
05/04/2020
Post Graduate Thesis
Yes
Type of Trial
Interventional
Type of Study
Unani
Study Design
Randomized, Parallel Group, Active Controlled Trial
Public Title of Study
A clinical research trial to find the safety and effectiveness of asgand and brahmi in underactive thyroid gland function
Scientific Title of Study
A Randomized,Active-Controlled,Assessor-Blinded,Parallel Group Clinical Study to evaluate the safety and efficacy of Asgand and Brahmi in the Management of Qillat-e-Darqiyyat Asli (Primary Hypothyroidism)
Trial Acronym
PGJV
Secondary IDs if Any
Secondary ID
Identifier
NIL
NIL
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
Name
juveria jabeen
Designation
PG Scholar
Affiliation
National Research Institute of Unani Medicine for Skin Disorders
Address
National Research Institute of Unani Medicine for Skin Disorders,Erragadda,hyderabad. National Research Institute of Unani Medicine for Skin Disorders,Erragadda,hyderabad. Hyderabad TELANGANA 500038 India
Phone
8978812833
Fax
Email
juveriaanam@gmail.com
Details of Contact Person Scientific Query
Name
Qamar uddin
Designation
Professor
Affiliation
National Research Institute of Unani Medicine for Skin Disorders
Address
old building,1st floor room no.115 National Research Institute of Unani Medicine for Skin Disorders,Erragadda,hyderabad. Hyderabad TELANGANA 500038 India
Phone
8700027178
Fax
Email
ccrumhqrsnd58@gmail.com
Details of Contact Person Public Query
Name
juveria jabeen
Designation
PG Scholar
Affiliation
National Research Institute of Unani Medicine for Skin Disorders
Address
PG department moalajat,new building ground floor,male OPD room no.1 National Research Institute of Unani Medicine for Skin Disorders,Erragadda,hyderabad. Hyderabad TELANGANA 500038 India
Phone
8978812833
Fax
Email
juveriaanam@gmail.com
Source of Monetary or Material Support
National Research Institute of Unani Medicine for Skin Disorders, AG Colony Road, Opp. ESI Hospital, Erragadda, Hyderabad-500 038
Primary Sponsor
Name
National Research Institute of Unani Medicine for Skin Disorders Hyderabad
Address
National Research Institute of Unani Medicine for Skin Disorders Hyderabad
Type of Sponsor
Research institution and hospital
Details of Secondary Sponsor
Name
Address
NIL
NIL
Countries of Recruitment
India
Sites of Study
No of Sites = 1
Name of Principal
Investigator
Name of Site
Site Address
Phone/Fax/Email
juveria jabeen
National Research Institute of Unani Medicine for Skin Disorders, Hyderabad
PG department moalajat,new building ground floor,male OPD room no.1 Hyderabad TELANGANA
Asgand and Brahmi 6 gms powder twice daily orally with water after meals.
Comparator Agent
Levothyroxine
50 mcg 2 tablets once daily orally with water before meals in morning
Inclusion Criteria
Age From
19.00 Year(s)
Age To
60.00 Year(s)
Gender
Both
Details
Patients of any gender
Patients in the age group between 19 and 60 years
Patients with Symptomatic Subclinical Primary Hypothyroidism
Patients with Clinical Primary Hypothyroidism
TSH ranging 5-10mg/dl
ExclusionCriteria
Details
Patients aged <19years or >60 years
Asymptomatic cases of Subclinical Primary Hypothyroidism
Severe/ complicated cases of Clinical Primary Hypothyroidism
Patients with Drug-induced Hypothyroidism
Patients on radiotherapy for head and neck region
ï‚· Patients who have undergone thyroidectomy
ï‚· Pregnant or Lactating Women
ï‚· Significant Pulmonary/ Cardiovascular/ Hepatic/ Renal Diseases
ï‚· Known cases of Immunocompromised states (HIV/ AIDS, etc.)/ Malignancies
ï‚· Patients with Diabetes Mellitus
ï‚· Patients with history of hypersensitivity to Asgand or Brahmi ï‚· Patient not willing to attend treatment schedule regularly
Method of Generating Random Sequence
Computer generated randomization
Method of Concealment
An Open list of random numbers
Blinding/Masking
Outcome Assessor Blinded
Primary Outcome
Outcome
TimePoints
Clinical assessment will be done at 0, 2, 4 ,6 and 8 weeks and the response to treatment will be assessed using the following parameters:
1. Decrease in serum TSH level
2. Increase in serum Free T4 level
3. Improvement in the symptoms & signs of hypothyroidism as assessed by reduction in Zulewski’s clinical score after treatment
2nd week
4th week
6th week
8th week
Secondary Outcome
Outcome
TimePoints
Lab investigation
0 and 8 weeks
Target Sample Size
Total Sample Size="45" Sample Size from India="45" Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials" Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials"
Phase of Trial
Phase 2
Date of First Enrollment (India)
01/05/2020
Date of Study Completion (India)
Applicable only for Completed/Terminated trials
Date of First Enrollment (Global)
Date Missing
Date of Study Completion (Global)
Applicable only for Completed/Terminated trials
Estimated Duration of Trial
Years="1" Months="6" Days="0"
Recruitment Status of Trial (Global)
Not Applicable
Recruitment Status of Trial (India)
Not Yet Recruiting
Publication Details
NIL
Individual Participant Data (IPD) Sharing Statement
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Brief Summary
Need for
the Study
Primary hypothyroidism refers to hormone
deficiency caused by intrinsic thyroid gland dysfunction that disrupts the
synthesis and secretion of T4 and T3. Primary hypothyroidism is one of the most
common endocrine conditions, occurring in 5% of individuals. Mild hypothyroidism
is present in as many as 15% of older adults. Hypothyroidism is more common
in women.
Hypothyroidism
continues to grow significantly in the country particularly among women. A survey conducted by Indian Thyroid Society
depicts one in ten adults in India suffer from hypothyroidism. According
to survey, the disease is more prevalent among women who are three times more
likely to be affected by hypothyroidism than men especially in the age group
of 46-54 years. A significant proportion of patient population may go
undetected and untreated even as it continues to impair the daily quality of
life, work performance and economic productivity [14].
Thyroid hormone deficiency affects
almost all body functions; and hypothyroidism if left untreated, may lead to
complications such as infertility, delirium, dementia, cerebellar ataxia, seizures,
psychosis (myxedema madness), confusion, myxedema coma, hypothermia, severe cardiac
failure (myxedema heart), pericardial effusions, etc.
In conventional medicine, levothyroxine is being used effectively in
the management of hypothyroidism, but it can suppress the TSH to subnormal
range and can cause serious side effects on bone density and cardiac function,
such as osteoporosis, atrial fibrillation, myocardial ischaemia, etc. Therefore,
there is a need to develop safe and effective drug for the management of Qillat-e-DarqiyyatAá¹£li
(Primary Hypothyroidism).
In a
recent survey conducted by American Thyroid Association demonstrated that patients
taking natural preparations, rather than synthetic hormone replacement
therapy or combination therapy, were more satisfied with their treatment
[20]. Asgand (Withania somnifera) and
Brahmi (Bacopa monnieri) have been used for centuries in Unani system
of medicine for various ailments; and a combination of Asgand and Brahmi
is being used for the management of depression, anxiety and chronic stress[22]; none of the studies have evaluated the effect
of this drug combination in hypothyroidism. However, it has been shown in
most of the pharmacological studies that both the drugs can stimulate the
thyroid gland to produce more T4 hormone [15-17,19,23,24].
Keeping these facts in mind, it has been
decided to conduct a research work entitled “A Randomized,
Active-Controlled, Assessor-Blinded, Parallel Group Clinical Study to
evaluate the safety and efficacy of Asgand and Brahmi in the
Management of Qillat-e-DarqiyyatAá¹£li (Primary Hypothyroidism)â€.
Review of Literature
The thyroid gland is a
butterfly-shaped endocrine gland that is located in the lower front of the
neck. The thyroid’s job is to make thyroid hormones, which are secreted into
the blood and then carried to every tissue in the body. Thyroid hormone helps
the body use energy, stay warm and keep the brain, heart, muscles, and other organs
working as they should. Hypothyroidism is an underactive thyroid gland [1].
Hypothyroidism means that the thyroid gland can’t make enough thyroid hormone
to keep the body running normally. When thyroid hormone levels are too low,
the body’s cells can’t get enough thyroid hormone and the body’s processes
start slowing down and shows the symptoms like tiredness, weakness, dry skin, feeling cold, hair loss, difficulty
concentrating, poor memory, constipation, weight gain with poor appetite,
dyspnoea, hoarse voice, menorrhagia (later oligomenorrhoea or amenorrhoea),
paraesthesia, impaired hearing; and signs like dry coarse skin, cool
peripheral extremities, puffy face, hands, and feet (myxoedema), diffuse
alopecia, bradycardia, peripheral edema, delayed tendon reflex relaxation, Carpal
Tunnel Syndrome, and serous cavity effusions [2].
As such hypothyroidism has not been
described in Unani classical literature, but some of the clinical features
associated with this disease are very much similar to those described in the
context of Su’-i-MizÄj BÄrid (abnormal cold temperament). According to
Unani literature, the normal temperament of the thyroid gland is hot [3],
but in hypothyroidism it changes from hot to abnormal cold temperament (Su’-i-MizÄj
BÄrid). Some Unani scholars consider hypothyroidism as BalghmaÄ«
(Phlegmatic) disease. Ghlaba-i-Balgham (domination of phlegmatic
humour) is characterized by bradycardia, low volume pulse, sluggishness of
skeletal muscles, puffiness, peripheral edema, cool peripheral extremities,
sluggish thinking. These signs and symptoms are found in patients with
hypothyroidism [4]. The signs and symptoms of Su’-i-MizÄj BÄrid
(abnormal cold temperament) include Khushk wa Khurdarī Jild (dry and
coarse skin), Shuḥūb (skin pallor), LisÄn SamÄ«k (thick tongue),
Fará¹ al-Nawm (excessive sleep), TakÄnwaKasalmandi
(lethargy and somnolence), Nabá¸Baá¹Ä«waMutafÄwit
(low volume pulse), KhafaqÄn (palpitation), Tahabbuj (puffiness
of face), Kund Zahni (diminished intellectual functions), Ḍu‘f
al-Shahwa (loss of libido), Ḥuṣr (constipation), Ḍu‘f
al-IshtiḥÄ’ (decreased appetite), [5-9,18,21] etc; and these
features coincides with the clinical manifestations of Qillat-e-Darqiyyat
(hypothyroidism). Thus, Su’-i-MizÄj BÄrid including Su’-i-MizÄj BalghmaÄ«
may beinterpreted with the clinical presentations of Qillat-e-Darqiyyat
(hypothyroidism). Although the ancient Unani physicians have described a
common disorder of thyroid gland in their literature as goiter (enlargement
of thyroid gland) and itstreatment.
BuqrÄt (Hippocrates) (460-337 BC) narrated in
context to the glands that “when glands of the neck become diseased
themselves, they become tubercular and produce strumaâ€. The term “struma†is
still used in some European countries (e.g. Austria, Italy) as the medical
designation of goiter.
IsmÄ‘il JurjÄnī’s ’Treasure of Medicine’
first associated with exophthalmos (protrusion of the eyes), we now associate
it with Grave’s disease (goiter). ‘AlÄ« ibn ‘AbbÄs MajÅ«sÄ« (d. 994 AD) stated
that the Waram which occurs due to Balgham-e-Ghalīz results in
Ghayngha (goiter) which are similar to glands. Ibn Hubal BaghdÄdÄ« (1121-1213
AD) mentioned exophthalmic goiter under the heading Juḥūẓ al-‘Ayn (exophthalmos)
in his book, “KitÄb al-MukhtÄrÄt fi’l Ṭibbâ€. He narrated as:“The main cause of Juḥūẓ
al-‘Ayn is accumulation of matter. The matter may be liquid or gaseous in
nature. These matters accumulate in the vessels of the eyes result in dilatation
of the vessels. Collectively we can say that increased pressure of vessels of
eyes is the cause of diseaseâ€.
According to Ibn SÄ«nÄ (Avicenna), the
signs of phlegm being predominant are excessive pallor, flabbiness of body, cold
and moist skin, excessive salivation and viscid saliva. Thirst is diminished
especially in elderly persons except of course when the acid phlegm predominates.
A weak digestion with acid eructation, pale urine, excessive sleepiness, flabby
muscles, mental dullness and a soft pulse of slow rate and speed are
characteristics of this condition. According to this, the line of treatment
when a temperamental abnormality is simple, i.e., without any complicating
factor, its treatment is counteraction [7].